GEHC GE HealthCare Technologies ...

Nasdaq


$ 78.10 $ 0.88 (1.14 %)    

Friday, 24-Oct-2025 19:44:26 EDT
QQQ $ 617.50 $ 6.52 (1.07 %)
DIA $ 472.45 $ 4.92 (1.05 %)
SPY $ 677.25 $ 5.49 (0.82 %)
TLT $ 91.47 $ 0.04 (0.04 %)
GLD $ 378.59 $ -1.27 (-0.34 %)
$ 78.14
$ 77.69
$ 76.97 x 500
$ 78.14 x 35
$ 77.14 - $ 78.33
$ 57.57 - $ 94.66
2,600,338
na
35.47B
$ 1.29
$ 15.83
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-30-2025 06-30-2025 10-Q
2 04-30-2025 03-31-2025 10-Q
3 02-13-2025 12-31-2024 10-K
4 10-30-2024 09-30-2024 10-Q
5 07-31-2024 06-30-2024 10-Q
6 04-30-2024 03-31-2024 10-Q
7 02-06-2024 12-31-2023 10-K
8 10-31-2023 09-30-2023 10-Q
9 07-25-2023 06-30-2023 10-Q
10 04-25-2023 03-31-2023 10-Q
11 02-15-2023 12-31-2022 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 ge-healthcare-receives-ce-mark-for-carevance-patient-monitor-expanding-access-to-advanced-monitoring-across-europe

Built on GE HealthCare's 50+ years of clinical excellence in patient monitoring, Carevance is an advanced, reliable monitor...

 ge-healthcare-partnering-with-the-queens-health-systems-duke-health-to-enhance-hospital-operations-patient-care-through-new-ai-driven-hospital-operations-platform

GE HealthCare (NASDAQ:GEHC) today announced collaborations with two leading U.S. health systems—The Queen's Health Systems ...

 btig-maintains-buy-on-ge-healthcare-techs-raises-price-target-to-89

BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $87 to $89.

 barclays-initiates-coverage-on-ge-healthcare-techs-with-equal-weight-rating-announces-price-target-of-86

Barclays analyst Matt Miksic initiates coverage on GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight rating and announce...

 citigroup-downgrades-ge-healthcare-techs-to-neutral-lowers-price-target-to-83

Citigroup analyst Joanne Wuensch downgrades GE HealthCare Techs (NASDAQ:GEHC) from Buy to Neutral and lowers the price targe...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

 bloomberg-ge-healthcare-is-said-to-explore-selling-stake-in-china-business

https://www.bloomberg.com/news/articles/2025-09-18/ge-healthcare-is-said-to-explore-selling-stake-in-china-business?srnd=homepa...

 ge-healthcare-announced-agreement-to-acquire-icometrix-no-financial-terms-disclosed

The anticipated acquisition aligns with GE HealthCare's precision care strategy with the goal of strengthening the company&...

 ge-healthcare-announces-a-distribution-and-services-agreement-with-cardionavix-to-expand-us-access-to-flyrcado-cardiac-pet-imaging-agent

GE HealthCare's agreement with CardioNavix, a part of the CDL Nuclear Technologies services group, further broadens the rea...

 ge-healthcare-launches-vivid-pioneer-ultrasound-system-with-ce-mark-and-fda-clearance

GE HealthCare (NASDAQ:GEHC) today announced the launch of the Vivid™ Pioneer, its most advanced, ultra-premium and adaptive car...

 citigroup-maintains-buy-on-ge-healthcare-techs-raises-price-target-to-93

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $89...

 morgan-stanley-maintains-equal-weight-on-ge-healthcare-techs-lowers-price-target-to-74

Morgan Stanley analyst Patrick Wood maintains GE HealthCare Techs (NASDAQ:GEHC) with a Equal-Weight and lowers the price tar...

 ge-healthcare-core-operating-margin-faces-tariffs-heat-raises-annual-outlook

GE HealthCare posted better-than-expected Q2 earnings and revenue and raised its 2025 EPS and free cash flow guidance on strong...

 ge-healthcare-techs-raises-fy2025-adj-eps-guidance-from-390-410-to-443-463-vs-407-est

2025 guidanceToday, the Company raises 2025 full-year guidance, reflective of healthy capital investment trends, operational ex...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION